Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enseval Putera Megatrading Tbk. (EPMT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Enseval Putera Megatrading Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Enseval Putera Megatrading Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Enseval Putera Megatrading Tbk. trades at Rp2,330 (market cap 6.23T, 3.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Enseval Putera Megatrading Tbk. is far larger — about 37.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 3.1K). Which is the better fit depends on your goals.

EPMTOBAT
Market Cap
6.23T167.37B
Volume
3.1K71K
Lot
31710
Turnover
7.21M17.51M
Average Price
2,325.48246.63
Value
7.21M17.51M
Indicative Equilibrium Price
246
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EPMT
View details
OBAT
View details

About Enseval Putera Megatrading Tbk.

PT. Enseval Putera Megatrading Tbk, formerly PT Arya Gupta Cempaka, was established based on deed No. 64 dated October 26, 1998 of Mrs. Rukmasanti Hardjasatya,SH, notary public in Jakarta. The company’s articles of association have been amended several times, most recently by deed No. 200 dated June 30, 1997 of Mrs. Poerbaningsih Adi Warsito, SH, notary public in Jakarta, concerning the changes of the company’s articles of association to comply with Corporate Law no. 1 year 1995, the increase in the company’s authorized capital and the change in par value per share from Rp 1,000 to Rp 500.

Read more on EPMT

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT